Dow Up0.25% Nasdaq Up0.65%

Mast Therapeutics, Inc. (MSTX)

-NYSE MKT
0.34 Down 0.00(1.15%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
Total Revenue -   -   -  
Cost of Revenue -   -   -  
Gross Profit -   -   -  
Operating Expenses
Research Development28,264  19,435  12,902  
Selling General and Administrative10,963  9,759  8,597  
Non Recurring -   -   -  
Others146  85  40  
Total Operating Expenses -   -   -  
Operating Income or Loss (39,373) (29,279) (21,539)
Income from Continuing Operations
Total Other Income/Expenses Net134  577  59  
Earnings Before Interest And Taxes(39,239)(28,702)(21,480)
Interest Expense603   -   -  
Income Before Tax(39,842)(28,702)(21,480)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(39,842)(28,702)(21,480)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (39,842) (28,702) (21,480)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (39,842) (28,702) (21,480)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.